mirtazapine has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damasceno, A | 1 |
| von Glehn, F | 1 |
| Martinez, AR | 1 |
| Longhini, AL | 1 |
| Deus-Silva, L | 1 |
| Brandão, CO | 1 |
| Santos, LM | 1 |
| Damasceno, BP | 1 |
1 other study available for mirtazapine and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Early onset of natalizumab-related progressive multifocal leukoencephalopathy.
Topics: Antibodies, Monoclonal, Humanized; Glatiramer Acetate; Humans; Immunologic Factors; Immunosuppressiv | 2011 |